Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0N0QC
|
||||
| Former ID |
DNCL002147
|
||||
| Drug Name |
GV1001
|
||||
| Drug Type |
Vaccine
|
||||
| Indication | Pancreatic cancer [ICD9: 140-199, 140-229, 157, 210-229; ICD10:C25] | Phase 3 | [523876] | ||
| Company |
KAEL-GemVax
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C85H146N26O21
|
||||
| Canonical SMILES |
CCC(C)C(C(=O)N1CCCC1C(=O)NC(CCCCN)C(=O)O)NC(=O)C(CC2=CC<br />=CC=C2)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CCCN=C<br />(N)N)NC(=O)C(C(C)O)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC<br />(C)C)NC(=O)C(C)NC(=O)C3CCCN3C(=O)C(CCCN=C(N)N)NC(=O)C(C<br />)NC(=O)C(CCC(=O)O)N
|
||||
| InChI |
1S/C85H146N26O21/c1-12-47(8)65(81(130)111-38-22-30-63(111)78(127)102-56(82(131)132)25-16-17-33-86)108-75(124)60(42-51-23-14-13-15-24-51)106-70(119)53(26-18-34-94-83(88)89)99-72(121)58(40-45(4)5)104-71(120)54(27-19-35-95-84(90)91)100-79(128)66(50(11)113)109-76(125)61(43-112)107-74(123)59(41-46(6)7)105-73(122)57(39-44(2)3)103-68(117)49(10)98-77(126)62-29-21-37-110(62)80(129)55(28-20-36-96-85(92)93)101-67(116)48(9)97-69(118)52(87)31-32-64(114)115/h13-15,23-24,44-50,52-63,65-66,112-113H,12,16-22,25-43,86-87H2,1-11H3,(H,97,118)(H,98,126)(H,99,121)(H,100,128)(H,101,116)(H,102,127)(H,103,117)(H,104,120)(H,105,122)(H,106,119)(H,107,123)(H,108,124)(H,109,125)(H,114,115)(H,131,132)(H4,88,89,94)(H4,90,91,95)(H4,92,93,96)/t47-,48-,49-,50+,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,65-,66-/m0/s1
|
||||
| InChIKey |
YTSOUHWRRQDQIK-QAXVQDKQSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Telomerase reverse transcriptase | Target Info | [528486] | ||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.